IMMUNOCORE HLDGS ADS/1 Strategic Asset Allocation Index
IMMUNOCORE HLDGS ADS/1 strategic asset allocation index. IMMUNOCORE HLDGS ADS/1 (6YG) has a Strategic Asset Allocation Index of 0.0% as of December 2022. Strategic assets (PP&E of €- plus long-term investments of €137.00K) total €137.00K, measured against net assets of €338.90 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See IMMUNOCORE HLDGS ADS/1 (6YG) balance sheet quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of IMMUNOCORE HLDGS ADS/1 (2022–2022)
Strategic asset allocation index of IMMUNOCORE HLDGS ADS/1 from 2022 to 2022. This chart shows how IMMUNOCORE HLDGS ADS/1's Strategic Asset Allocation Index has evolved across 1 annual periods from 2022 to 2022. As of December 2022, the index stands at 0.0%, representing strategic assets of €137.00K against net assets of €338.90 Million EUR. Check 6YG intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
IMMUNOCORE HLDGS ADS/1 Strategic Asset Allocation Index by Year (2022–2022)
IMMUNOCORE HLDGS ADS/1 strategic asset allocation index by year from 2022 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for IMMUNOCORE HLDGS ADS/1 from 2022 to 2022, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 6YG market cap.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.0% | €137.00K | €- | €137.00K | €338.90 Million | — |